Inhibition of Histone Demethylases by 4-Carboxy-2,2′-Bipyridyl Compounds

被引:64
作者
Chang, Kai-Hsuan [1 ]
King, Oliver N. F. [1 ]
Tumber, Anthony [2 ]
Woon, Esther C. Y. [1 ]
Heightman, Tom D. [2 ]
McDonough, Michael A. [1 ]
Schofield, Christopher J. [1 ]
Rose, Nathan R. [1 ]
机构
[1] Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England
[2] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England
基金
英国惠康基金; 英国生物技术与生命科学研究理事会;
关键词
bipyridyl derivatives; epigenetics; histone demethylases; inhibitors; 2-oxoglutarate; HYPOXIA-INDUCIBLE FACTOR; PROLYL; 4-HYDROXYLASE; SPECIFICITY; SERIES; JMJD2A;
D O I
10.1002/cmdc.201100026
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Exploiting epigenetics: 2-Oxoglutarate (2OG)-dependent histone lysine demethylases, such as JMJD2E, are potential therapeutic targets in a range of diseases. Through structure-activity relationship studies and analyses, we identified a potent 4-carboxy-2,2'-bipyridyl compound, which inhibits JMJD2E with an IC50 value of 110nM, representing a 66-fold improvement over the lead compound. These bipyridyl derivatives bind in the 2-oxoglutarate binding site. © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
引用
收藏
页码:759 / 764
页数:6
相关论文
共 21 条
[1]   Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease [J].
Cloos, Paul A. C. ;
Christensen, Jesper ;
Agger, Karl ;
Helin, Kristian .
GENES & DEVELOPMENT, 2008, 22 (09) :1115-1140
[2]   The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3 [J].
Cloos, Paul A. C. ;
Christensen, Jesper ;
Agger, Karl ;
Maiolica, Alessio ;
Rappsilber, Juri ;
Antal, Torben ;
Hansen, Klaus H. ;
Helin, Kristian .
NATURE, 2006, 442 (7100) :307-311
[3]   Specificity and mechanism of JMJD2A, a trimethyllysine-specific histone demethylase [J].
Couture, Jean-Francois ;
Collazo, Evys ;
Ortiz-Tello, Patricia A. ;
Brunzelle, Joseph S. ;
Trievel, Raymond C. .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2007, 14 (08) :689-695
[4]   Mildronate: Cardioprotective action through carnitine-lowering effect [J].
Dambrova, M ;
Liepinsh, E ;
Kalvinsh, I .
TRENDS IN CARDIOVASCULAR MEDICINE, 2002, 12 (06) :275-279
[5]   Inhibition of prolyl 4-hydroxylase in vitro and in vivo by members of a novel series of phenanthrolinones [J].
Franklin, TJ ;
Morris, WP ;
Edwards, PN ;
Large, MS ;
Stephenson, R .
BIOCHEMICAL JOURNAL, 2001, 353 :333-338
[6]   Therapeutic approaches to organ fibrosis [J].
Franklin, TJ .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (01) :79-89
[7]   NOVEL INHIBITORS OF PROLYL 4-HYDROXYLASE .5. THE INTRIGUING STRUCTURE-ACTIVITY-RELATIONSHIPS SEEN WITH 2,2'-BIPYRIDINE AND ITS 5,5'-DICARBOXYLIC ACID-DERIVATIVES [J].
HALES, NJ ;
BEATTIE, JF .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (24) :3853-3858
[8]   Design, Synthesis, Enzyme-Inhibitory Activity, and Effect on Human Cancer Cells of a Novel Series of Jumonji Domain-Containing Protein 2 Histone Demethylase Inhibitors [J].
Hamada, Shohei ;
Suzuki, Takayoshi ;
Mino, Koshiki ;
Kosek, Koichi ;
Oehme, Felix ;
Flamme, Ingo ;
Ozasa, Hiroki ;
Itoh, Yukihiro ;
Ogasawara, Daisuke ;
Komaarashi, Haruka ;
Kato, Aiko ;
Tsumoto, Hiroki ;
Nakagawa, Hidehiko ;
Hasegawa, Makoto ;
Sasaki, Ryuzo ;
Mizukami, Tamio ;
Miyata, Naoki .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (15) :5629-5638
[9]   Synthesis and activity of N-oxalylglycine and its derivatives as Jumonji C-domain-containing histone lysine demethylase inhibitors [J].
Hamada, Shohei ;
Kim, Tae-Dong ;
Suzuki, Takayoshi ;
Itoh, Yukihiro ;
Tsumoto, Hiroki ;
Nakagawa, Hidehiko ;
Janknecht, Ralf ;
Miyata, Naoki .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (10) :2852-2855
[10]   Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor [J].
Ivan, M ;
Haberberger, T ;
Gervasi, DC ;
Michelson, KS ;
Günzler, V ;
Kondo, K ;
Yang, HF ;
Sorokina, I ;
Conaway, RC ;
Conaway, JW ;
Kaelin, WG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) :13459-13464